Sowers M, Zhang D, Hollis B W, Shapiro B, Janney C A, Crutchfield M, Schork M A, Stanczyk F, Randolph J
Department of Epidemiology, University of Michigan, Ann Arbor 48109-2029, USA.
Am J Clin Nutr. 1998 Feb;67(2):284-91. doi: 10.1093/ajcn/67.2.284.
The postpartum period can be a time when profound changes in calcium metabolism and bone mineral density (BMD) occur, particularly in association with lactation. We investigated the hypothesis that calciotrophic hormones [1,25-dihydroxyvitamin D, 25-hydroxyvitamin D, and parathyroid hormone (PTH)] are different by lactation practice or hormone status [PTH-related peptide (PTHrP), estradiol, and prolactin] and have a potential role in the bone loss and recovery associated with lactation. 1,25-Dihydroxyvitamin D, 25-hydroxyvitamin D, PTH, femoral BMD, PTHrP, prolactin, estradiol, and bone turnover markers were measured at 2 wk and at 2, 4, 6, 12, and 18 mo postparturition in 115 postpartum women aged 20-40 y (parity: 0-1). Lumbar spine BMD was measured at 2 wk and at 6, 12, and 18 mo during the postpartum period. PTH, 1,25-dihydroxyvitamin D, and 25-hydroxyvitamin D concentrations were nonlinear across the 18-mo postpartum period. Between baseline and 18 mo postparturition, PTH and 1,25-dihydroxyvitamin D concentrations did not decline, while there was a substantial decline in 25-hydroxyvitamin D concentrations. PTH, 1,25-dihydroxyvitamin D, and 25-hydroxyvitamin D concentrations did not differ by lactation practice or by PTHrP, estradiol, or prolactin status. These classic calciotrophic hormones were not associated with concentrations of bone turnover markers or changes in BMD in lactating women. In summary, patterns of change in calciotrophic hormones (PTH, 1,25-dihydroxyvitamin D, and 25-hydroxyvitamin D) in the 18-mo postpartum period appeared to be independent of PTHrP, estradiol, prolactin, or lactation status and were not associated with bone turnover markers. These data do not support the hypothesis that these three calciotrophic hormones are a central part of the calcium mobilization associated with the bone loss of lactation.
产后期可能是钙代谢和骨矿物质密度(BMD)发生深刻变化的时期,尤其是与哺乳相关时。我们研究了以下假说:钙营养激素[1,25 - 二羟维生素D、25 - 羟维生素D和甲状旁腺激素(PTH)]因哺乳方式或激素状态[甲状旁腺激素相关肽(PTHrP)、雌二醇和催乳素]而有所不同,并在与哺乳相关的骨质流失和恢复中发挥潜在作用。在115名年龄在20 - 40岁(产次:0 - 1)的产后女性中,于产后2周以及产后2、4、6、12和18个月测量了1,25 - 二羟维生素D、25 - 羟维生素D、PTH、股骨BMD、PTHrP、催乳素、雌二醇和骨转换标志物。在产后期的2周以及6、12和18个月测量了腰椎BMD。在产后18个月期间,PTH、1,25 - 二羟维生素D和25 - 羟维生素D的浓度呈非线性变化。在产后基线至18个月期间,PTH和1,25 - 二羟维生素D的浓度没有下降,而25 - 羟维生素D的浓度大幅下降。PTH、1,25 - 二羟维生素D和25 - 羟维生素D的浓度在哺乳方式或PTHrP、雌二醇或催乳素状态方面没有差异。这些经典的钙营养激素与哺乳期女性的骨转换标志物浓度或BMD变化无关。总之,产后18个月期间钙营养激素(PTH、1,25 - 二羟维生素D和25 - 羟维生素D)的变化模式似乎独立于PTHrP、雌二醇、催乳素或哺乳状态,并且与骨转换标志物无关。这些数据不支持这三种钙营养激素是与哺乳期骨质流失相关的钙动员核心部分这一假说。